The Greenbrier Resort, White Sulphur Springs WV
April 29-May 1, 2022
Click on the exhibitor/sponsor logo to view more information on the organization's website.
|
Fortis Surgical, LLC is the exclusive distributor of Arthrex products throughout the Commonwealth of Virginia. Together with Arthrex, we are a global medical device company and leader in new product development and medical education in orthopedics. With a corporate mission of helping surgeons treat their patients better, Arthrex has pioneered the field of arthroscopy and developed more than 13,000 innovative products and surgical procedures to advance minimally invasive orthopedics worldwide. Please visit https://www.arthrex.com/ http://fortis-surgical.com/ |
|
Medacta is an international orthopaedics company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta’s products and surgical techniques are characterized by innovation.
Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) technique for hip replacements.
Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated “MySolutions” technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures. |
|
Fidia Pharma USA Inc. provides innovative products for orthopedic and musculoskeletal care. Our hyaluronan-based viscosupplements include HYALGAN®, the first HA approved in the US for osteoarthritis knee pain, HYMOVIS®, a 2-injection non-crosslinked hydrogel, and 3-injection TRILURON®. RichPlat Ortho™ delivers safe, consistent, high-quality Platelet Rich Plasma with a closed-system kit. Visit fidiapharma.us to learn more. |
|
At Heron, we are unwavering in our commitment to improve the lives of patients. We aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies that bring together our innovative science and technologies with well-known pharmacology to deliver medicines that matter. |
|
Irrimax Corporation is focused on reducing infections, healthcare costs and improving patient outcomes.
Irrimax manufactures Irrisept Antimicrobial Wound Lavage, a single-use, manual, self-contained irrigation device comprised of 0.05% Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water for Irrigation, United States Pharmacopeia (USP). Visit www.irrisept.com to learn more or request a sample. |
|
440innovations, llc has provided innovative, practical, & efficient solutions for healthcare & surgeons since 2011. |
|
American Medical Imaging (AMI) brings expertise, experience and innovation together into one powerful partner. Our customized solutions in medical imaging technology extend across all life-cycle management services from capital equipment planning, equipment sales and IT solutions, to maintenance and repair, to installation, removal and disposal. |
|
ACO Med Supply is a premier company that offers a broad and extensive line of products covering all areas of healthcare. ACO Med Supply has grown to include areas in medical/surgical supplies, rehabilitation equipment, cold therapy and casting products, all while keeping the most advanced orthopaedic equipment to date. We work with top suppliers to provide our consumers with the latest and most durable medical supplies available.
DJO Global, Inc. is a leading global provider of high-quality, orthopedic devices, with a broad range of products used for rehabilitation, pain management and physical therapy. We also develop, manufacture and distribute a broad range of surgical reconstructive implant products.
|
|
Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology. Endo Pharmaceuticals is an Endo company (NASDAQ: ENDP), a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Learn more at www.endo.com or www.endopharma.com.
|
|
Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Visit www.exac.com for more information and connect with us on LinkedIn, VuMedi, YouTube and Instagram. |
|
We represent proprietary, cutting edge orthopaedic products in the Mid-Atlantic. |
|
Osteal Therapeutics is a musculoskeletal therapeutics company developing medications for the treatment of orthopedic infections and their consequences. We are dedicated to relentless innovation because we believe that better tools will enable orthopedic surgeons to rapidly and reliably resolve infection so their patients can get back to living. |
|
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, visit www.pacira.com. |
|
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement. |